Hasegawa Kosei 長谷川幸清

… Alternative Names

HASEGAWA Kosei 長谷川幸清

Less

Researcher Number	30534193
Other IDs	https://orcid.org/0000-0002-1903-7001
Affiliation (Current)	2025: 埼玉医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2016 – 2024: 埼玉医科大学, 医学部, 教授 2013 – 2014: 埼玉医科大学, 医学部, 准教授 2010 – 2012: 埼玉医科大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related Except Principal Investigator Basic Section 56040:Obstetrics and gynecology-related / Basic Section 49020:Human pathology-related / Basic Section 52040:Radiological sciences-related
Keywords	Principal Investigator 卵巣癌 / 癌 / 免疫 / バイオマーカー / 発現制御 / 遺伝子 / マイクロRNA / T細部 / 腫瘍微小環境 / 漿液性癌 … More / 個別化治療 / 免疫療法 / 発現解析 / 腫瘍免疫 / 卵巣 / 免疫学 / エクソーム / 予後 / T細胞 / ネオアンチゲン / 卵巣明細胞癌 / 遺伝子発現 / 婦人科腫瘍学 … More Except Principal Investigator 卵巣癌 / 子宮体癌 / 低酸素誘導因子 / HIF-1α / 低酸素 / 非コードRNA / RNA結合蛋白質 / 卵巣がん / 全エクソンシークエンス / 遺伝子変異頻度 / 融合遺伝子 / BRCA2 / BRCA1 / myChoice CDx / Todai OncoPanel / プレシジョンメディシン / 婦人科がん / 薬剤感受性 / ゲノム解析 / RNAシークエンス / Todai Oncopanel / リアルワールドデータ / 子宮頸癌 / オルガノイド / マルチオミクス解析 / がん遺伝子パネル検査 / 組織型 / 組織学 / 機械学習 / MRI / 子宮内膜癌 / テクスチャ解析 / HDAC / HIF-1 / silibinin / PD-L1 / 卵巣漿液性癌 / 卵巣明細胞癌 / ヒストン脱アセチル化酵素 / Silibinin / ARID1A / ヒストン脱アセチル化酵素（HDAC） / 低酸素誘導因子（HIF） / 高異型度漿液性癌 / 卵巣明細胞癌（OVCCC） Less

Exploring Suppressive Immunity Mechanisms in the Ovarian Cancer Microenvironment Using Tumor-Infiltrating T CellsPrincipal Investigator
- Principal Investigator
  
  長谷川幸清
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Saitama Medical University
卵巣がんにおけるRNA結合蛋白質・非コードRNA複合体の同定、機能解明と臨床応用
- Principal Investigator
  
  竹岩俊彦
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology
卵巣癌における低酸素誘導因子（HIF）の抑制機構の解明と治療応用への試み
- Principal Investigator
  
  安田政実
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 49020:Human pathology-related
- Research Institution
  Saitama Medical University
個別化治療戦略ための子宮内膜癌のMRIテクスチャ解析に基づく診断法の確立
- Principal Investigator
  
  小澤栄人
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Saitama Medical University
Genomic profiling and drug screening among organoids derived from ovarian cancer patients
- Principal Investigator
  
  Oda Katsutoshi
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  The University of Tokyo
卵巣癌の個別化治療を目指した免疫プロファイルに基づく包括的バイオマーカーの開発Principal Investigator
- Principal Investigator
  
  長谷川幸清
- Project Period (FY)
  2019 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Saitama Medical University
How is the histological subtype of the ovarian carcinoma associated with hypoxia-related factors in terms of its chemotherapeutic resistance
- Principal Investigator
  
  Yasuda Masanori
- Project Period (FY)
  2018 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 49020:Human pathology-related
- Research Institution
  Saitama Medical University
Neoantigen and local immune profile in ovarian clear cell carcinomaPrincipal Investigator
- Principal Investigator
  
  HASEGAWA Kosei
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Saitama Medical University
Biomarker discovery using miRNA expression array in patients with ovarian cancer treated with dose-dense Paclitaxel combined with intraperitoneal chemotherapy of CarboplatinPrincipal Investigator
- Principal Investigator
  
  HASEGAWA Kosei
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Saitama Medical University
MicroRNA as a new target for ovarian cancer therapyPrincipal Investigator
- Principal Investigator
  
  HASEGAWA Kosei
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Saitama Medical University

[Book] 婦人科系がん免疫細胞治療II2011
- Author(s)
  長谷川幸清
- Publisher
  幻冬舎
- Data Source
  KAKENHI-PROJECT-22791542
[Journal Article] A case of ovarian endometrioid carcinoma: Atypical MR imaging2024
- Author(s)
  Inoue K, Yasuda M, Hasegawa K, Kajihara T, Kozawa E.
- Journal Title
  
  Radiol Case Rep.
  
  Volume: 19 Issue: 6 Pages: 2245-2248
- DOI
  10.1016/j.radcr.2024.02.074
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K06928
[Journal Article] Evaluation of Uterine Carcinosarcoma and Uterine Endometrial Carcinoma Using Magnetic Resonance Imaging Findings and Texture Features.2024
- Author(s)
  Tsuchihashi S, Nagawa K, Shimizu H, Inoue K, Okada Y, Baba Y, Hasegawa K, Yasuda M, Kozawa E
- Journal Title
  
  Cureus
  
  Volume: 16
- DOI
  10.7759/cureus.55916
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K06928
[Journal Article] Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma2024
- Author(s)
  Miyama Y, Ogasawara A, Hasegawa K, Yasuda M.
- Journal Title
  
  International Journal of Gynecological Pathology
  
  Volume: 00 Issue: 4 Pages: 1-11
- DOI
  10.1097/pgp.0000000000001002
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K06928
[Journal Article] Co-clinical study of [fam-] trastuzumab deruxtecan (DS8201a) in patient-derived xenograft models of uterine carcinosarcoma and its association with clinical efficacy.2023
- Author(s)
  Yagishita S, Nishikawa T, Yoshida H, Shintani D, Sato S, Miwa M, Suzuki M, Yasuda M, Ogitani Y, Jikoh T, Yonemori K, Hasegawa K, Hamada A.
- Journal Title
  
  Clin Cancer Res.
  
  Volume: CCR-22-3861.
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06928
[Journal Article] Co-clinical study of [fam-] trastuzumab deruxtecan (DS8201a) in patient-derived xenograft models of uterine carcinosarcoma and its association with clinical efficacy.2023
- Author(s)
  Yagishita S, Nishikawa T, Yoshida H, Shintani D, Sato S, Miwa M, Suzuki M, Yasuda M, Ogitani Y, Jikoh T, Yonemori K, Hasegawa K, Hamada A.
- Journal Title
  
  Clin Cancer Res.
  
  Volume: CCR-22
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06997
[Journal Article] Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy.2023
- Author(s)
  Yagishita S, Nishikawa T, Yoshida H, Shintani D, Sato S, Miwa M, Suzuki M, Yasuda M, Ogitani Y, Jikoh T, Yonemori K, Hasegawa K, Hamada A.
- Journal Title
  
  Clin Cancer Res.
  
  Volume: 29 Issue: 12 Pages: 2239-2249
- DOI
  10.1158/1078-0432.ccr-22-3861
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K06928
[Journal Article] Diagnostic utility of a conventional MRI-based analysis and texture analysis for discriminating between ovarian thecoma-fibroma groups and ovarian granulosa cell tumors.2022
- Author(s)
  Nagawa K, Kishigami T, Yokoyama F, Murakami S, Yasugi T, Takaki Y, Inoue K, Tsuchihashi S, Seki S, Okada Y, Baba Y, Hasegawa K, Yasuda M, Kozawa E.
- Journal Title
  
  J Ovarian Res.
  
  Volume: 15 Issue: 1 Pages: 65-65
- DOI
  10.1186/s13048-022-00989-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06928, KAKENHI-PROJECT-18K06997
[Journal Article] Up-regulation of HDAC6 Results in Poor Prognosis and Chemoresistance in Patients With Advanced Ovarian High-grade Serous Carcinoma2021
- Author(s)
  YANO MITSUTAKE、MIYAZAWA MARIKO、OGANE NAOKI、OGASAWARA AIKO、HASEGAWA KOSEI、NARAHARA HISASHI、YASUDA MASANORI
- Journal Title
  
  Anticancer Research
  
  Volume: 41 Issue: 3 Pages: 1647-1654
- DOI
  10.21873/anticanres.14927
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06997, KAKENHI-PROJECT-19K16778, KAKENHI-PROJECT-21K06928
[Journal Article] Impact of TP53 immunohistochemistry on the histological grading system for endometrial endometrioid carcinoma2019
- Author(s)
  Yano Mitsutake、Ito Kozue、Yabuno Akira、Ogane Naoki、Katoh Tomomi、Miyazawa Mariko、Miyazawa Masaki、Hasegawa Kosei、Narahara Hisashi、Yasuda Masanori
- Journal Title
  
  Modern Pathology
  
  Volume: 印刷中 Issue: 7 Pages: 1023-1031
- DOI
  10.1038/s41379-019-0220-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K06997, KAKENHI-PROJECT-16K11157
[Journal Article] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma2019
- Author(s)
  Yano Mitsutake、Katoh Tomomi、Miyazawa Mariko、Miyazawa Masaki、Ogane Naoki、Miwa Maiko、Hasegawa Kosei、Narahara Hisashi、Yasuda Masanori
- Journal Title
  
  Scientific Reports
  
  Volume: 9 Issue: 1 Pages: 2397-2397
- DOI
  10.1038/s41598-019-38653-0
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K08355, KAKENHI-PROJECT-16K11157, KAKENHI-PROJECT-18K06997
[Journal Article] Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma2018
- Author(s)
  Imai Yuichi、Hasegawa Kosei、Matsushita Hirokazu、Fujieda Nao、Sato Sho、Miyagi Etsuko、Kakimi Kazuhiro、Fujiwara Keiichi
- Journal Title
  
  Oncology Letters
  
  Volume: 15 Pages: 6457-6468
- DOI
  10.3892/ol.2018.8101
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H04708, KAKENHI-PROJECT-18H02696, KAKENHI-PROJECT-15K10577, KAKENHI-PROJECT-16K07162, KAKENHI-PROJECT-16K11152
[Journal Article] Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management.2018
- Author(s)
  Oda K, Hamanishi J, Matsuo K, Hasegawa K
- Journal Title
  
  Gynecol Oncol
  
  Volume: 151 Issue: 2 Pages: 381-389
- DOI
  10.1016/j.ygyno.2018.09.001
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K09249, KAKENHI-PROJECT-17K19591, KAKENHI-PROJECT-18H02945, KAKENHI-PROJECT-16K11152
[Journal Article] The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.2017
- Author(s)
  Matsushita H, Hasegawa K, Oda K, Yamamoto S, Nishijima A, Imai Y, Asada K, Ikeda Y, Karasaki T, Fujiwara K, Aburatani H, Kakimi K.
- Journal Title
  
  Oncoimmunology
  
  Volume: 6 Issue: 8 Pages: e1338996-e1338996
- DOI
  10.1080/2162402x.2017.1338996
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07162, KAKENHI-PROJECT-16K11152, KAKENHI-PROJECT-15H04942, KAKENHI-PROJECT-16H04708
[Journal Article] Synchronous mucinous metaplasia and neoplasia of the female genital tract with external urethral meatus neoplasm: A case report.2015
- Author(s)
  Ikeda Y, Yasuda M, Kato, T, Yano Y, Kurosaki A, Hasegawa K.
- Journal Title
  
  Gynecol Oncol Reports.
  
  Volume: online journalのためなし Pages: 27-30
- DOI
  10.1016/j.gore.2015.02.001
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Impact of molecular classification on clinical management of ovarian cancer2015
- Author(s)
  Hasegawa K
- Journal Title
  
  Gan to Kagaku Ryoho
  
  Volume: 42 Pages: 166-8
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors.2015
- Author(s)
  Sasaki Y, Miwa K, Yamashita K, Sunakawa Y, Shimada K, Ishida H, Hasegawa K, Fujiwara K, Kodaira M, Fujiwara Y, Namiki M, Matsuda M, Takeuchi Y, Katsumata N.
- Journal Title
  
  Invest New Drugs.
  
  Volume: 33 Pages: 332-40
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.2015
- Author(s)
  Matsuo K, Yoshino K, Hasegawa K, Murakami R, Ikeda Y, Adachi S, Hiramatsu K, Yokoyama T, Nishimura M, Sheridan TB, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Fotopoulou C, Roman LD, Sood AK.
- Journal Title
  
  Gynecol Oncol.
  
  Volume: 136 Issue: 2 Pages: 198-204
- DOI
  10.1016/j.ygyno.2014.12.006
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592527, KAKENHI-PROJECT-25293338
[Journal Article] The Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictive Marker of Peritoneal Dissemination in Epithelial Ovarian Cancer Patients.2015
- Author(s)
  Ikeda Y, Hasegawa K, Kurosaki A, Miyara A, Hanaoka T, Shintani D, Imai Y, Nishikawa T, Oda K, Fujiwara K.
- Journal Title
  
  Oncol Res Treat.
  
  Volume: 未
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] がん免疫療法の最前線～卵巣癌に対する特異的癌免疫療法2014
- Author(s)
  長谷川幸清、黒崎亮、藤原恵一
- Journal Title
  
  産科と婦人科
  
  Volume: 81 Pages: 172-177
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Development, Optimization, and Validation of Novel anti-TEM1/CD248 Affinity Agent for Optical Imaging in Cancer.2014
- Author(s)
  Li C, Wang J, Hu J, Feng Y, Hasegawa K, Peng X, Duan X, Zhao A, Mikitsh J, Muzykantov V, Chacko AM, Pryma D, Dunn S, Coukos G.
- Journal Title
  
  Oncotarget.
  
  Volume: 5 Pages: 6994-7012
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial.2014
- Author(s)
  Takeshima N, Matoda M, Abe M, Hirashima Y, Kai K, Nasu K, Takano M, Furuya K, Sato S, Itamochi H, Tsubamoto H, Hasegawa K, Terao K, Otsuki T, Kuritani K, Ito K.
- Journal Title
  
  Support Care Cancer.
  
  Volume: 22 Issue: 11 Pages: 2891-8
- DOI
  10.1007/s00520-014-2280-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Uterine Corpus and Cervix.2014
- Author(s)
  Hasegawa K, Nagao S, Yasuda M, Millan D, Viswanathan AN, Glasspool RM, Devouassoux-Shisheboran M, Covens A, Lorusso D, Kurzeder C, Kim JW, Gladieff L, Bryce J, Friedlander M, Fujiwara K.
- Journal Title
  
  Int J Gynecol Cancer.
  
  Volume: 24 Pages: 90-5
- DOI
  10.1097/igc.0000000000000297
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma.2014
- Author(s)
  Matsuo K, Sheridan TB, Mabuchi S, Yoshino K, Hasegawa K, Studeman KD, Im DD, Rosenshein NB, Roman LD, Sood AK.
- Journal Title
  
  Gynecol Oncol.
  
  Volume: Epubのため未 Issue: 3 Pages: 473-479
- DOI
  10.1016/j.ygyno.2014.03.563
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] 子宮頸がんに対するbevacizumabの第III相試験2014
- Author(s)
  長谷川幸清、池田悠至、藤原恵一
- Journal Title
  
  腫瘍内科
  
  Volume: 13 Pages: 311-317
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Antibody-Based Tumor Vascular Theranostics Targeting the Human Endosialin/TEM1 In Vivo.2014
- Author(s)
  Li C, Chacko AM, Hu J, Hasegawa K, Swails J, Grasso L, El-Deiry WS, Nicolaides N, Muzykantov VR, Divgi CR, Coukos G.
- Journal Title
  
  Cancer Biol Ther.
  
  Volume: 15 Issue: 4 Pages: 443-51
- DOI
  10.4161/cbt.27825
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Effect of Lymphovascular Space Invasion on2014
- Author(s)
  Koji Matsuo, Kiyoshi Yoshino, Kosuke Hiramatsu, Chiaki Banzai, Kosei Hasegawa, Masanori Yasuda, Masato Nishimura, Todd B. Sheridan, Yuji Ikeda, Yasuhiko Shiki, Seiji Mabuchi, Takayuki Enomoto, Tadashi Kimura, Keiichi Fujiwara, Lynda D. Roman, and Anil K. Sood
- Journal Title
  
  Obstet Gynecol
  
  Volume: 123 Issue: 5 Pages: 957-65
- DOI
  10.1097/aog.0000000000000240
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590424, KAKENHI-PROJECT-24592527
[Journal Article] Feasibility Study of Combination Chemotherapy with Paclitaxel, Doxorubicin and Cisplatin without Prophylactic Granulocyte Colony-stimulating Factor Injection for Intermediate-to-high risk or Recurrent Endometrial Cancer.2014
- Author(s)
  Nagao S, Nishikawa T, Hanaoka T, Kurosaki A, Iwasa N, Hasegawa K, Fujiwara K.
- Journal Title
  
  Jpn J Clin Oncol.
  
  Volume: 44 Issue: 11 Pages: 1040-4
- DOI
  10.1093/jjco/hyu124
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Clinical trials of neoadjuvant chemotherapy for ovarian cancer: what do we gain after an EORTC trial and after two additional ongoing trials are completed?2013
- Author(s)
  Fujiwara K, Kurosaki A, Hasegawa K.
- Journal Title
  
  Curr Oncol Rep.
  
  Volume: 15 Issue: 3 Pages: 197-200
- DOI
  10.1007/s11912-013-0313-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer.2013
- Author(s)
  Fujiwara K, Nagao S, Aotani E, Hasegawa K.
- Journal Title
  
  Expert Opin Pharmacother.
  
  Volume: 14 Issue: 13 Pages: 1797-806
- DOI
  10.1517/14656566.2013.820705
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Estrogen-producing endometrioid adenocarcinoma resembling sex cord-stromal tumor of the ovary: a review of four postmenopausal cases.2012
- Author(s)
  Katoh T, Yasuda M, Hasegawa K, Kozawa E, Maniwa J, Sasano H.
- Journal Title
  
  Diagn Pathol.
  
  Volume: 28 Issue: 1 Pages: 164-164
- DOI
  10.1186/1746-1596-7-164
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590424, KAKENHI-PROJECT-24592527
[Journal Article] 子宮肉腫の臨床像と治療2012
- Author(s)
  長谷川幸清
- Journal Title
  
  日本婦人か病理学会誌
  
  Volume: 3 Pages: 57-61
- Data Source
  KAKENHI-PROJECT-24592527
[Journal Article] Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma : a feasibility study2012
- Author(s)
  Nagao S, Iwasa N, Kurosaki A, Nishikawa T, Ohishi R, Hasegawa K, Goto T, Fujiwara K
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 22(1) Pages: 70-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791542
[Journal Article] Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma : A Feasibility Study2012
- Author(s)
  Shoji Nagao
- Journal Title
  
  International Journal of Gynecological Cancer
  
  Volume: 22 Issue: 1 Pages: 70-75
- DOI
  10.1097/igc.0b013e318234f927
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791542, KAKENHI-PROJECT-24592527
[Journal Article] Single nedaplatin treatment as salvage chemotherapy for platinum/taxane-resistant/refractory epithelial ovarian, tubal and peritoneal cancers2010
- Author(s)
  Goto T, Takano M, Ohishi R, Iwasa N, Shimizu M, Hasegawa K, Nagao S, Fujiwara K
- Journal Title
  
  J Obstet Gynaecol Res
  
  Volume: 36(4) Pages: 764-8
- NAID
  10031121691
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791542
[Journal Article] Spontaneously ruptured endometrioma associated with endometrioid adenocarcinoma : MR findings2010
- Author(s)
  Kozawa E, Matsuo Y, Hasegawa K, Fujiwara K, Sakurai T, Kimura F
- Journal Title
  
  Magn Reson Med Sci
  
  Volume: 9(4) Pages: 233-6
- NAID
  10027851598
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791542
[Presentation] MRIを用いたテクスチャ解析によるタイプIとタイプIIの子宮内膜癌の評価2023
- Author(s)
  井上快児、長谷川幸清、安田政実、小澤栄人　他
- Organizer
  第52回日本磁気共鳴医学会大会
- Data Source
  KAKENHI-PROJECT-21K07604
[Presentation] EVALUATION OF UTERINE ENDOMETRIAL CARCINOMA HISTOLOGICAL GRADES USING MAGNETIC RESONANCE IMAGING TEXTURE ANALYSES2023
- Author(s)
  Kozawa E, Inoue K, Hasegawa K, Yasuda M, et al.
- Organizer
  International Gynecologic Cancer Society
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07604
[Presentation] A novel clinically applicable biomarker for testing HRD status based on the mutational signatures: Results for the phase 2 trial of olaparib maintenance monotherapy in patients with primary high-grade ovarian carcinoma.2023
- Author(s)
  Akira Nishijima, Kosei Hasegawa, Sho Sato, Kazuyoshi Kato, Mayuyo Mori, Shoji Nagao, Noriomi Matsumura, ...... Hiroyuki Aburatani, Katsutoshi Oda
- Organizer
  SGO Annual Meeting 2023
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H03074
[Presentation] Integrative genomic/epigenomic analysis in clear cell ovarian cancers.2021
- Author(s)
  Katsutoshi Oda, Akira Nishijima, Kosei Hasegawa, Hiroyuki Aburatani
- Organizer
  The 80th Annual Meeting of the Japanese Cancer Association. Symposium 11. Genomic analysis toward future clinical application.
- Invited
- Data Source
  KAKENHI-PROJECT-21H03074
[Presentation] Distinct Clinicopathological Features of Endometrial Mesonephric-like Adenocarcinoma2020
- Author(s)
  Yano M, Katoh T, Yabuno A, Ogane N, Ito K, Miyazawa M, Miyazawa M, Hasegawa K, Narahara H, Yasuda M
- Organizer
  USCAP 109th AnnualMeeting 2020
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K06997
[Presentation] Stratification of endometrial endometrioid carcinoma with a support of p53 immuhohistochemical status.2019
- Author(s)
  Mitsutake Yano, Kozue Ito, Akira Yabuno, Tomomi Katoh, Naoki Ogane, Mariko Miyazawa, Masaki Miyazawa, Kosei Hasegawa, Hisashi Narahara, Masanori Yasuda
- Organizer
  The 108th Annual Meeting of United States and Canadian Academy of Pathology (USCAP)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K06997
[Presentation] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma2019
- Author(s)
  Mitsutake Yano, Tomomi Katoh, Mariko Miyazawa, Masaki Miyazawa, Naoki Ogane, Maiko Miwa, Kosei Hasegawa, Hisashi Narahara, Masanori Yasuda
- Organizer
  北米病理学会USCAP
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K06997
[Presentation] 卵巣明細胞癌におけるARID1AとHDAC6の相関2019
- Author(s)
  矢野光剛，伊藤梢絵，三輪真唯子，加藤智美，宮澤麻里子，宮澤昌樹，大金直樹，長谷川幸清，楢原久司，安田政実
- Organizer
  第108回日本病理学会総会
- Data Source
  KAKENHI-PROJECT-18K06997
[Presentation] New Biomarker of Cancer Immunotherapy for Gynecologic Cancer2018
- Author(s)
  Kosei Hasegawa
- Organizer
  60th JSGO/ IGCS 2018
- Data Source
  KAKENHI-PROJECT-16K11152
[Presentation] A subgroup with a T- cell inflamed phenotype in homologous recombination proficient high-grade serous ovarian carcinoma2018
- Author(s)
  Kosei Hasegawa, Hirokazu Matsushita, Katsutoshi Oda, Shogo Yamamoto, Kayo Asada, Akira Yabuno Akira Nishijima, Takahiro Karasaki, Yuji Ikeda, Keiichi Fujiwara, Hiroyuki Aburatani and Kazuhiro Kakimi
- Organizer
  The 77th Annual Meeting of the Japanese Cancer Association
- Data Source
  KAKENHI-PROJECT-16K11152
[Presentation] Combination approaches of immunotherapy and targeted therapy in cancer treatment2018
- Author(s)
  Kosei Hasegawa
- Organizer
  60th JSGO/ IGCS 2018
- Data Source
  KAKENHI-PROJECT-16K11152
[Presentation] High frequency of neoantigens per mutation is a risk factor for recurrence in ovarian clear cell carcinoma2017
- Author(s)
  Kosei Hasegawa
- Organizer
  日本癌学会学術講演会
- Data Source
  KAKENHI-PROJECT-16K11152
[Presentation] The use of an engineered sendai virus in urokinase-type plasminogen activator targeted therapy of ovarian cancer2012
- Author(s)
  Kosei Hasegawa, Tatsuya Hanaoka, Akira Kurosaki, Keiichi Fujiwara
- Organizer
  71th Japanese Cancer Association,
- Place of Presentation
  Sapporo
- Data Source
  KAKENHI-PROJECT-24592527
[Presentation] Soluble MUC1 as a Biomarker for Epithelial Ovarian Cancer2012
- Author(s)
  K. Hasegawa, T. Hanaoka, A. Kurosaki, A. Miyara, K. Abe, T. Kawamura, T. Sekino, T. Kato, M. Yasuda, K. Fujiwara
- Organizer
  14th Biennial Meeting of the International Gynecologic Cancer Society,
- Place of Presentation
  Vancouver, Canada
- Data Source
  KAKENHI-PROJECT-24592527
[Presentation] シンポジウム:がん薬物療法のバイオマーカー・婦人科がん2011
- Author(s)
  長谷川幸清
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋市(名古屋国際会議場)(招待講演)
- Year and Date
  2011-10-27
- Data Source
  KAKENHI-PROJECT-22791542
[Presentation] 健常人末梢血単核球を用いたカツマキソマブのin vitroにおける抗腫瘍効果の検討2011
- Author(s)
  長谷川幸清
- Organizer
  第50回日本婦人科腫瘍学会
- Place of Presentation
  札幌市(札幌コンベンションセンター)
- Year and Date
  2011-07-23
- Data Source
  KAKENHI-PROJECT-22791542
[Presentation] 健常人末梢血単核球を用いたカツマキソマブのin vitroにおける抗腫瘍効果の検討2011
- Author(s)
  長谷川幸清
- Organizer
  第50回日本婦人科腫瘍学会
- Place of Presentation
  札幌
- Year and Date
  2011-07-23
- Data Source
  KAKENHI-PROJECT-22791542
[Presentation] シンポジウム:がん薬物療法のバイオマーカー-婦人科がん2011
- Author(s)
  長谷川幸清
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-27
- Data Source
  KAKENHI-PROJECT-22791542
[Presentation] Catumaxomab shows comparable anti-tumor activity in vitro with immune effector cells from Caucasian or Asian (Japanese and Korean) healthy subjects2011
- Author(s)
  Kosei Hasegawa
- Organizer
  2011 ASCO annual meeting
- Place of Presentation
  シカゴ(アメリカ)
- Year and Date
  2011-06-02
- Data Source
  KAKENHI-PROJECT-22791542
[Presentation] 婦人科がんに対する維持化学療法のエビデンス構築に向けて2011
- Author(s)
  長谷川幸清
- Organizer
  第9回山形骨盤外科研究会
- Place of Presentation
  山形
- Year and Date
  2011-01-22
- Data Source
  KAKENHI-PROJECT-22791542
[Presentation] 子宮体部病変に対するMRI拡散強調画像を用いたADC値の有用性の検討2010
- Author(s)
  長谷川幸清
- Organizer
  第62回日本産科婦人科学会学術講演会
- Place of Presentation
  東京国際フォーラム(東京都)
- Year and Date
  2010-04-23
- Data Source
  KAKENHI-PROJECT-22791542
[Presentation] Redirected antitumor activity of an engineered Sendai virus vector in ovarian cancer cells
- Author(s)
  K. Hasegawa, A. Miyara, T. Hanaoka, A. Kurosaki, Y. Ueda, M. Inoue2 M. Hasegawa and K. Fujiwara
- Organizer
  AACR/JCA 2013
- Place of Presentation
  Maui, USA
- Data Source
  KAKENHI-PROJECT-24592527
[Presentation] 婦人科がんに対する維持化学療法のエビデンス構築に向けて
- Author(s)
  長谷川幸清
- Organizer
  第５６回日本婦人科腫瘍学会学術講演会
- Place of Presentation
  宇都宮
- Year and Date
  2014-07-17 – 2014-07-19
- Invited
- Data Source
  KAKENHI-PROJECT-24592527
[Presentation] Soluble folate receptor alpha as a biomarker for epithelial ovarian cancer
- Author(s)
  Kosei Hasegawa, Akira Kurosaki, Tetsuo Sekino, Keiichi Fujiwara
- Organizer
  72th Japanese Cancer Association
- Place of Presentation
  Yokohama
- Invited
- Data Source
  KAKENHI-PROJECT-24592527

1. Oda Katsutoshi (30359608)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
2. Yasuda Masanori (50242508)

# of Collaborated Projects: 3 results

# of Collaborated Products: 18 results
3. 松下博和 (80597782)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
4. 矢野光剛 (70817064)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
5. 宮澤昌樹 (30624572)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
6. 垣見和宏 (80273358)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
7. EGUCHI Hidetaka (00260232)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. WADA Satoshi (80438837)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 宮澤麻里子 (80637091)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. 小澤栄人 (90255109)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
11. 田口歩 (60756782)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 谷川道洋 (70706944)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 竹岩俊彦 (20635643)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 井上聡 (40251251)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Hasegawa Kosei 長谷川 幸清

HASEGAWA Kosei 長谷川 幸清

Research Projects

Research Products

Co-Researchers

Exploring Suppressive Immunity Mechanisms in the Ovarian Cancer Microenvironment Using Tumor-Infiltrating T CellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

卵巣がんにおけるRNA結合蛋白質・非コードRNA複合体の同定、機能解明と臨床応用

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

卵巣癌における低酸素誘導因子（HIF）の抑制機構の解明と治療応用への試み

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

個別化治療戦略ための子宮内膜癌のMRIテクスチャ解析に基づく診断法の確立

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Genomic profiling and drug screening among organoids derived from ovarian cancer patients

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

卵巣癌の個別化治療を目指した免疫プロファイルに基づく包括的バイオマーカーの開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

How is the histological subtype of the ovarian carcinoma associated with hypoxia-related factors in terms of its chemotherapeutic resistance

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Neoantigen and local immune profile in ovarian clear cell carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Biomarker discovery using miRNA expression array in patients with ovarian cancer treated with dose-dense Paclitaxel combined with intraperitoneal chemotherapy of CarboplatinPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

MicroRNA as a new target for ovarian cancer therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 婦人科系がん免疫細胞治療II2011

Author(s)

Publisher

Data Source

[Journal Article] A case of ovarian endometrioid carcinoma: Atypical MR imaging2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Evaluation of Uterine Carcinosarcoma and Uterine Endometrial Carcinoma Using Magnetic Resonance Imaging Findings and Texture Features.2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma2024

Hasegawa Kosei 長谷川幸清

HASEGAWA Kosei 長谷川幸清